Clinical trial
Transverse Abdominis Plane Block for Anterior Approach Spine Surgery: A Prospective Randomized Study
Name
35RC15_8933_TAP-ALIF
Description
Therapeutic, prospective, randomized, double blind, placebo-controlled, in intention to treat, monocentric study to evaluate the analgesic efficacy of a bilateral TAP block after spine surgery with 24 hours morphine consumption
Trial arms
Trial start
2016-11-07
Estimated PCD
2019-05-25
Trial end
2019-05-25
Status
Completed
Phase
Early phase I
Treatment
TAP block ropivacaine
Arms:
TAP block ropivacaine
TAP block placebo
Arms:
TAP block placebo
General anesthesia
Induction PROPOFOL 10mg/ml REMIFENTANIL 50 μg/ml CISATRACURIUM 2mg/ml if necessary DEXAMETHASONE 8 mg KETAMINE 0,15mg/kg Maintenance PROPOFOL 10mg/ml REMIFENTANIL 50 μg/ml
Arms:
TAP block placebo, TAP block ropivacaine
Size
43
Primary endpoint
Morphine consumption in the first 24 hours after spine surgery by anterior approach
24 hours
Eligibility criteria
Inclusion Criteria:
* Patient with age above 18 years old
* Patients scheduled for spine surgery by anterior approach
* Patient who signed an informed consent form
Exclusion Criteria:
* Allergy to ropivacaine
* Weight \< 50 kg
* Contra indication to TAP block : sepsis in the point of draining, bleeding disorder
* Contra indication to paracetamol: severe hepatic insufficiency
* Contra indication to ketoprofen: age ≥ 75 years, renal insufficiency, previous gastric ulcer, allergy
* Contra indication to nefopam: severe cardiac insufficiency, glaucoma, prostate hypertrophy, allergy
* Known allergy to active substance or at least to one excipient (propofol, paracetamol, morphine, remifentanil, cisatracurium)
* Allergy to fentanyl, atracurium, or benzin sulfonic acid derivative, to propacetamol
* Convulsions or previous convulsive disorder
* Severe respiratory insufficiency
* Abnormal hemostasis or anticoagulant treatment because of possible intramuscular injection
* Morphine intake 24 hours before surgery
* Chronic use of morphine, gabapentin, pregabalin
* Pregnancy or breastfeeding
* Patient unable to use Patient Controlled Analgesia (PCA) (old patient depends...)
* Patients subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE2'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'TRIPLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 43, 'type': 'ACTUAL'}}
Updated at
2023-05-24
1 organization
3 products
3 indications
Organization
Rennes University HospitalProduct
TAP block ropivacaineIndication
Spinal SurgeryIndication
Low Back PainIndication
SpondylolisthesisProduct
TAP block placeboProduct
General anesthesia